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Tian).Aims: The aim of the study was to investigate the relationship between I27L variant of HNF-1a gene and
type 2 diabetes mellitus (T2DM) in an/the oriental population.
Methods: We recruited 149 T2DM patients and 96 non-diabetes controls from China. The I27L polymor-
phism in HNF-1a gene was detected by PCR–RFLP analysis. A mete-analysis of previously published stud-
ies on I27L and T2DM of orient population and our new study was performed. Databases of MEDLINE,
CBM, and the Cochrane Library (CD-ROM) were electronically searched from January 1980 to April
2008. Analysis was performed by RevMan 4.2 software which was downloaded from website of Cochrane
collaboration.
Results: (1). The genotype distribution of I27L/exon1 polymorphism in the HNF-1a gene was in Hardy–
Weinberg equilibrium (v2 = 2.34, 0.05 < P < 0.1). The IL, LL genotype frequencies and L allelic frequency
were slightly higher in T2DM group than in controls (0.52, 0.14 and 0.40 in T2DM vs. 0.49, 0.08 and
0.33 in controls), but the difference were not statistically signiﬁcant, which indicated that 27L variant
did not increase the risk of T2DM in our small sample Chinese population. (2). Three published studies
concerning the Chinese population, two studies involving the Japanese population and our present study,
providing information on a total of 1225 unique subjects, were included in the meta-analysis. The results
showed that the 27L variant increased the prevalence of T2DM (OR 1.22, 95% CI 1.03–1.44, p = 0.02).
Conclusion: I27L polymorphism in the HNF-1a gene increases the risk of T2DM in the orient population
(Chinese and Japanese).
 2009 International Journal of Diabetes Mellitus. Published by Elsevier Ltd.
Open access under CC BY-NC-ND license.1. Introduction
Hepatocyte nuclear factor-1a (HNF-1a) is a liver-enriched
transcription factor that plays a role in the transcription regula-
tion of several genes involving glucose metabolism and islet
development. It has been conﬁrmed that some rare gene muta-
tions of this factor led to type 3 maturity-onset diabetes of the
young (MODY3) [1]. And it has been speculated that common
variants of this gene might play a role in the pathogenesis of
type 2 diabetes mellitus (T2DM). Recently, several genome-wide
scans have found evidence of linkage of type 2 diabetes to chro-
mosome 12q24, where the HNF-1a gene is located [2–4]. One ofellitus. Published by Elsevier Ltd.
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Othe commonest variants in HNF-1a gene, I27L/exon1, occurs in a
completely conserved region among humans, rats, mice and
hamsters, which is important for HNF-1a dimerization [5]. The
replacement of I (Isoleucine) with L (Leucine) might give rise
to a small conformational change and might thereby inﬂuence
DNA binding. Some studies have indicated that the I27L variant
was not only was associated with b cell dysfunction, but also
played a modest role in the pathogenesis of insulin resistance
[5,6]. All of this evidence indicates that I27L might be one of
the risk factors of T2DM.
A number of studies have investigated the relationship between
I27L polymorphism and T2DM, mainly concerning Caucasian pop-
ulations. The previous small size studies did not ﬁnd any associa-
tion [7–10]. Subsequent large population studies, however,
displayed inconsistent results. For instance, Winckler et al. [11]
genotyped I27L polymorphism in >4000 diabetic patients and con-
trol subjects from Sweden, Finland and Canada, and found a nom-
inally signiﬁcant association of 27L with T2DM, but theirpen access under CC BY-NC-ND license.
Fig. 1. Meta-analysis result of the relationship between HNF-1a 27L/exon1 and T2DM in East Asian population.
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matched controls of US and Polish ancestry, and the concurrent
study by Weedon et al. [12] in 5307 Caucasian T2DM and controls,
did not show any evidence of the association of 27L to T2DM.
Holmkvist et al. further evaluated their relationship, based on the
data of a case-control study (3736 Scandinavian cases and con-
trols) and two prospective studies, that is, thew Botnia prospective
study (2293 Finland non-diabetic subjects) and the Malmö Preven-
tion Project (MPP, 4873 Sweden individuals), their results showed
that the I27L polymorphism was associated with increased risk of
T2DM, odds ratio (OR) = 1.5 (p = 0.002; multiple logistic regres-
sion), particularly in elderly (age >60 years) and overweight (BMI
>25 kg/m2) patients (OR = 2.3, p = 0.002) [13]. Their ﬁndings pro-
posed a hypothesis that the I27L variant might cause subtle defects
in beta cell function which should become more easily manifested
during conditions of enhanced demand, e.g. insulin resistance as in
elderly overweight individuals.
People of oriental origin tended to be younger and less obese
than the Caucasian population at the onset of T2DM, which sug-
gested that oriental people have more vulnerable islet b cell func-
tion, or are more insulin resistant [14–16]. Therefore, oriental
people with 27L polymorphism should, in theory, be at increased
risk of T2DM, as is the case in older or overweight Caucasian pop-
ulations. A small number of studies involving the orient popula-
tion, however, failed to ﬁnd any association between 27L and
T2DM [9,17–20]. Due to limited sample size of these studies, a pos-
sible relationship might be still exist and need to be further inves-
tigated. The study here aimed to investigate the distribution of
I27L gene variance in T2DM patients and normal glucose tolerance
controls within Chinese Han nations from the Chengdu area, and to
investigate the relationship between the I27L and T2DM in Orient
population by pooling data for this study and other published
reports.2. Patients and methods
Case-control study 149 unrelated type 2 diabetic patients diag-
nosed according to the 1999 World Health Organization criteria
were recruited from Chendu city of China, which included 80 males
and 69 females, with a mean age 61.8 ± 10.1 years. Patients sus-
pected with other speciﬁc types of diabetes were excluded.
Ninety-six unrelated non-diabetic individuals, including 54 males
and 42 females, aged 60 years or more and with mean age
70.72 ± 6.71, served as controls. All participants gave informed
consent. HbA1c was measured using an ion-exchange high-perfor-
mance liquid chromatography method (Bio-Rad Diamat, Hercules,
CA). Plasma glucose levels were measured by using glucose oxidase
methods. Genomic DNA was extracted from peripheral leukocytes.
The I27L polymorphism was genotyped using a PCR–RFLP method,
as described elsewhere [10].2.1. Meta-analysis
We searched published articles in MEDLINE (Pubmed and OVID
Technologies), the Cochrane library (CD-ROM) and CBM respec-
tively, and searched meeting abstracts in ISI proceedings (http://
apps.isiknowledge.com). The key words ‘diabetes mellitus’, ‘hepa-
tocyte nuclear factor-1a’ and their synonyms or related terms were
used. Our search was limited to human studies that were pub-
lished in the English and Chinese literature. Publishing times were
limited from January 1980 to April 2008. Data extraction was con-
ducted by two investigators (Tao Chen and Xu Cao) and consensus
was achieved for all data. Studies were compared to eliminate
duplicated reports for the same patients, which included a contact
with investigators when necessary.
2.2. Statistical analysis
Chi square test was applied to assess any signiﬁcant difference
of allele frequencies and genotype frequencies. P < 0:05 (two-
tailed) was considered signiﬁcant. The meta-analyses were per-
formed on RevMan 4.2.8 (the Cochrane Collaboration, http://
www.cochrane.co.uk). The results were reported using odds ratios
and corresponding 95% conﬁdence intervals (95% CI) for dichoto-
mous data. Heterogeneity between trials was tested by both Chi
squared test and I-squared test. If there was no heterogeneity, a
ﬁxed-effect model was used. If heterogeneity was found, sensitiv-
ity analysis was conducted. If the reasons that led to the heteroge-
neity could not be found by sensitivity analysis, the random-effect
model was used.3. Results
In our case-control study, the genotype distribution of I27L/
exon1 polymorphism in the HNF-1a gene was in Hardy–Weinberg
equilibrium (v2 = 2.34, 0.05 < P < 0.1). The genotype frequencies
were II 0.34, IL 0.52, LL 0.14 in T2DM and II 0.43, IL 0.49, LL 0.08
in non-diabetic controls respectively, without signiﬁcantly statisti-
cal difference (v2 = 2.54, P > 0.05). The I allele and L allele were
0.60, 0.40 in T2DM group and 0.67, 0.33 in non-diabetic controls
respectively, the difference was not signiﬁcant also (v2 = 2.84,
P = 0.24).
Our electronic searches identiﬁed 27 reports about HNF-1a
gene variance and T2DM in orient population that were selected
for full text review; the completed list of these reports is available
on request. 23 (82.1%) papers were excluded because they did not
detect I27L polymorphism or present the information of this poly-
morphism. Five studies (17.9%) and our present study providing
information on a total of 1225 unique subjects (717 type 2 diabetic
patients and 508 controls) were subjected to the following meta-
analysis. Three published studies concerned Chinese population
Table 1
I27L allelic frequencies of HNF-1a gene in different studies of East Asian population.
Author Population DM Controls P
N Freq. (I/L) N Freq. (I/L)
Nishigori [17] Japanese 60 0.56/0.44 100 0.58/0.42 NS
Babaya [18] Japanese 57 0.47/0.53 88 0.52/0.48 NS
Rissanen [9] Chinese 105 0.5/0.5 51 0.61/0.39 NS
Fang [19] Chinese 154 0.55/0.45 93 0.62/0.38 NS
Yang Zhen [20] Chinese 192 0.61/0.39 80 0.59/0.41 NS
Present study Chinese 149 0.60/0.40 96 0.67/0.33 NS
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the frequencies of 27L ranged from 0.39 to 0.53 in diabetic pa-
tients, and from 0.33 to 0.48 in controls. Total 27L allele frequen-
cies were 0.43 in diabetic patients, a little higher than in controls
(0.40). Heterogeneity was not found between the six trials
(v2 = 3.83, P = 0.57, I2 = 0%). Thus, a ﬁxed-effects model was per-
formed. The result showed that 27L slightly increases the risk of
diabetes (OR 1.22, 95% CI 1.03–1.44, P = 0.02) (see Fig. 1).4. Discussion
Type 2 diabetes is a common human disease that is inﬂuenced
by both genetic and environmental factors. As in most common
diseases, very few variants have been rigorously proven to play a
role in the common form of type 2 diabetes. Up to now, only a
few gene variants, e.g. rs7903146 in TCF7L2, E23 K in KCNJ11,
and P12A in PPAR-c, are established as major genetic contributors
to T2DM in Caucasian population [21–23]. Their effects on T2DM in
the oriental population, however, were quite different [24–29]. For
instance, rs7903146 in TCF7L2 was the top one major genetic risk
factor for T2DM in population of European origin, but its allelic fre-
quency was much lower in the East Asian population than in Euro-
peans, and its association with T2DM were inconsistent among
studies [24,25,30]. As for P12A in PPAR-c gene, no association with
T2DM was found in the Chinese and Japanese populations [28,29].
What is more, the prevalence of T2DM was not uncommon, or was
even more common in the oriental population, as compared with
the Caucasian population [14]. All of this suggested that genetic
background to T2DM varied from Caucasian populations to oriental
populations, and there might be other potential risk factors
responsible for T2DM in the oriental population.
I27L polymorphism is located within the dimerization domain
of the HNF-1a gene, and the isoleucine amino acid is conserved
among several species, indicating a potential functional impor-
tance of this residue. In vitro study, 27L polymorphisms in the
HNF-1a gene showed decreased transcriptional activity on the tar-
get promoters glucose transporter 2 [13]. In vivo studies, I27L var-
iance was also indicated to have an effect on glucose metabolism.
For example, Ken et al. examined 52 healthy glucose-tolerant and
normotensive subjects and found that the 27L polymorphism is
associated with insulin resistance [6]. They then further investi-
gated 78 healthy subjects and found individuals with 27LL geno-
type may also have a declined b cell function [5].
In our case-control study, we found that the 27L allelic fre-
quency and 27IL/27LL genotypes frequencies were slightly higher
in the T2DM group than in non-diabetes control group (0.44,
0.52, 0.14 vs. 0.30, 0.49, 0.08), but the differences were not statis-
tically signiﬁcant. The 27L allelic frequency was similar to that ob-
tained from studies in Caucasian population, ranging from 0.21–
0.47 in T2DM patients and 0.26–0.45 in controls [9,17–20], and
was also similar to that of other studies in orient population, that
is, 0.39–0.53 in T2DM patients and 0.33–0.48 in controls [9,17–
20]. No relationship was found between 27L and T2DM in ourcase-control study, which was in line with other small sample
studies in orient populations [9,17–20].
We then performed a meta-analysis, by pooling together previ-
ously published studies and our new study. The results show that
27L has a positive association with diabetes (OR 1.22, 95% CI 1.03–
1.44). This result was in keeping with Holmkvist et al.’s recent ﬁnd-
ings that 27L variant increased the risk of T2DM, especially in el-
derly and overweight persons who were more insulin resistant
and/or deteriorated beta cell function [13]. It is known that
T2DM patients of Asian origin usually have a less BMI and a youn-
ger age at the onset or T2DM, which indicating orient population
might be more genetically susceptible to T2DM [14,16]. The caus-
ative mechanism is still undetermined, though it has been pro-
posed that the islet beta cell of East Asians were more vulnerable
in the setting of accumulating insulin resistance [15]. This meta-
analysis results corresponding with Holmkvist et al.’s ﬁndings,
which implied that a subtle defect of beta cell function caused by
the common variant of 27L variant might have a modest effect
on the onset of T2DM in a subset of high risk populations of T2DM.
The primary limitation of our study is the small sample size.
Even when combining previous published studies with our present
study, there are still only 1225 individuals. Publication bias is an-
other potential limitation. Small sample studies with negative re-
sults might not be published. We tried to minimize this effect by
search meeting abstracts via ISI proceedings (http://apps.isiknowl-
edge.com), but there still might be studies with negative result
could not be retrieved. Finally, the studied populations are mainly
Chinese and Japanese; no studies about Korea population and other
populations of East Asian origin were found.
From the present study, may we conclude that the common
amino acid polymorphism of the HNF-1a gene, I27L does seem-
ingly play a role in type 2 diabetes mellitus in oriental populations
(Chinese and Japanese). For the sake of potential limitations, this
result still needs to be further conﬁrmed by large population-based
studies.5. Declaration of competing interests
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